Evidence map›Paper›PMID 30842579›Full record

ArticleScientific reports2019

Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.

James Goodwine, Joel Gil, Amber Doiron, Jose Valdes, Michael Solis, Alex Higa, Stephen Davis, Karin Sauer

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Biofilm dispersion inbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Characterization ofFrontiers in microbiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Unraveling metabolic reprogramming inFrontiers in molecular biosciences · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Quorum-quenching enzyme Est816 assisted antibiotics against periodontitis induced byFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

James GoodwineDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.
Joel GilDepartment of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Amber DoironDepartment of Biomedical Engineering, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA.ORCID 0000-0002-6963-0989
Jose ValdesDepartment of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Michael SolisDepartment of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Alex HigaDepartment of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Stephen DavisDepartment of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Karin SauerDepartment of Biological Sciences, Binghamton Biofilm Research Center, Binghamton University, Binghamton, NY, 13902, USA. ksauer@binghamton.edu.
University of Miami · USBinghamton University · US

Funding

Pyruvate Depletion as Adjuntive Therapy for the Treatment of Biofilm-Related InfectionsR56AI127815 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI DAVIS, STEPHEN C, DOIRON, AMBER L · 2017 to 2017
$292k
NIAID NIH HHS R56 AI127815
6 · The paper itself

Abstract

The formation of biofilms is a developmental process initiated by planktonic cells transitioning to the surface, which comes full circle when cells disperse from the biofilm and transition to the planktonic mode of growth. Considering that pyruvate has been previously demonstrated to be required for the formation of P. aeruginosa biofilms, we asked whether pyruvate likewise contributes to the maintenance of the biofilm structure, with depletion of pyruvate resulting in dispersion. Here, we demonstrate that the enzymatic depletion of pyruvate coincided with the dispersion of established biofilms by S. aureus and laboratory and clinical P. aeruginosa isolates. The dispersion response was dependent on pyruvate fermentation pathway components but independent of proteins previously described to contribute to P. aeruginosa biofilm dispersion. Using porcine second-degree burn wounds infected with P. aeruginosa biofilm cells, we furthermore demonstrated that pyruvate depletion resulted in a reduction of biofilm biomass in vivo. Pyruvate-depleting conditions enhanced the efficacy of tobramycin killing of the resident wound biofilms by up to 5-logs. Our findings strongly suggest the management of pyruvate availability to be a promising strategy to combat biofilm-related infections by two principal pathogens associated with wound and cystic fibrosis lung infections.

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsBurnsCulture MediaDisease Models, AnimalFermentationHumansPseudomonas aeruginosaPseudomonas InfectionsPyruvic AcidStaphylococcus aureusSwineTobramycinAnti-Bacterial AgentsCulture MediaPyruvic AcidTobramycin

Identifiers

PMID30842579
PMCPMC6403282
OpenAlexW2919450116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.